GENinCode (LON:GENI) Shares Up 8.7% – Time to Buy?

GENinCode Plc (LON:GENI) shares traded up 8.7% on Tuesday . The company traded as high as GBX 1.14 and last traded at GBX 1.14. 10,131,498 shares changed hands during trading, an increase of 77% from the average session volume of 5,733,112 shares. The stock had previously closed at GBX 1.04.

GENinCode Trading Up 8.7%

The company has a current ratio of 2.80, a quick ratio of 15.89 and a debt-to-equity ratio of 7.17. The stock has a 50-day simple moving average of GBX 1.13 and a 200 day simple moving average of GBX 1.71. The company has a market cap of £8.23 million, a price-to-earnings ratio of -0.48 and a beta of 0.61.

About GENinCode

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.